TFS Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-62,283
| Closed | -$231K | – | 551 |
|
|
2017
Q2 | $231K | Sell |
62,283
-13,501
| -18% | -$50.1K | 0.09% | 404 |
|
|
2017
Q1 | $314K | Buy |
+75,784
| New | +$314K | 0.1% | 367 |
|
|
2016
Q4 | – | Sell |
-3,220
| Closed | -$32K | – | 993 |
|
|
2016
Q3 | $32K | Buy |
+3,220
| New | +$32K | 0.01% | 720 |
|
|
2016
Q2 | – | Sell |
-2,231
| Closed | -$17K | – | 1328 |
|
|
2016
Q1 | $17K | Sell |
2,231
-3,356
| -60% | -$25.6K | ﹤0.01% | 975 |
|
|
2015
Q4 | $74K | Sell |
5,587
-8,312
| -60% | -$110K | 0.01% | 684 |
|
|
2015
Q3 | $228K | Sell |
13,899
-10,716
| -44% | -$176K | 0.02% | 717 |
|
|
2015
Q2 | $552K | Sell |
24,615
-59,019
| -71% | -$1.32M | 0.05% | 492 |
|
|
2015
Q1 | $818K | Buy |
83,634
+69,527
| +493% | +$680K | 0.08% | 408 |
|
|
2014
Q4 | $161K | Sell |
14,107
-37,539
| -73% | -$428K | 0.02% | 853 |
|
|
2014
Q3 | $595K | Buy |
51,646
+12,466
| +32% | +$144K | 0.05% | 536 |
|
|
2014
Q2 | $762K | Sell |
39,180
-20,826
| -35% | -$405K | 0.06% | 501 |
|
|
2014
Q1 | $1.08M | Buy |
60,006
+26,724
| +80% | +$480K | 0.07% | 424 |
|
|
2013
Q4 | $351K | Buy |
33,282
+21,103
| +173% | +$223K | 0.02% | 1009 |
|
|
2013
Q3 | $151K | Sell |
12,179
-31,700
| -72% | -$393K | 0.01% | 1320 |
|
|
2013
Q2 | $413K | Buy |
+43,879
| New | +$413K | 0.02% | 982 |
|